Latest Memantine Stories
DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S.
- NAMZARIC is now available across the United States - DUBLIN, Ireland, May 18, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that NAMZARIC(TM) (memantine hydrochloride extended-release
- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec.
New comprehensive report “Memantine - Comprehensive patent search” elaborated by Ark Patent Intelligence is now available at MarketPublishers.com. London,
Blockbuster Status Awaits Novel DMTs and Lundbeck/Otsuka's Emerging Symptomatic Agent Lu-AE58054, According to Findings from Decision Resources Group BURLINGTON, Mass., July 21, 2014 /PRNewswire/
MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas,
BOSTON, Mass., May 23, 2014 /PRNewswire/ -- AZTherapies, Inc.
RnRMarketResearch.com adds "Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis" to its store. DALLAS, April 7, 2014 /PRNewswire-iReach/
LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
DUBLIN, February 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/l77qff/alzheimers ) has announced the addition of the "Concise
- A handkerchief.
- In general, any miraculous portrait of Christ.